​

Artivion (AORT) Stock Forecast, Price Target & Predictions

OverviewRevenueFinancialsChartTranscripts

AORT Stock Forecast

Artivion (AORT) stock forecast, based on 12 Wall Street analysts, predicts a 12-month average price target of $40.50, with a high of $45.00 and a low of $36.00. This represents a 62.00% increase from the last price of $25.00.

$15 $21 $27 $33 $39 $45 High: $45 Avg: $40.5 Low: $36 Last Closed Price: $25

AORT Stock Rating

Artivion stock's rating consensus is Buy, based on 12 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (83.33%), 2 Hold (16.67%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 12 2 10 0 Strong Sell Sell Hold Buy Strong Buy

AORT Price Target Upside V Benchmarks

TypeNameUpside
StockArtivion62.00%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks30.52%

Price Target Trends

1M3M12M
# Anlaysts-26
Avg Price Target-$40.50$47.00
Last Closing Price$25.00$25.00$25.00
Upside/Downside-62.00%88.00%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 2626---8
Jun, 2616---7
May, 2626---8
Apr, 26241--7
Mar, 26241--7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jun 16, 2026William PlovanicCanaccord Genuity$36.00$21.0770.86%44.00%
Jun 01, 2026John McAulayStifel Nicolaus$45.00$22.19102.79%80.00%
Mar 05, 2026John McAulayStifel Nicolaus$55.00$38.2643.75%120.00%
Dec 17, 2025William PlovanicCanaccord Genuity$51.00$45.9111.09%104.00%
Nov 07, 2025Suraj KaliaOppenheimer$50.00$45.739.34%100.00%
Aug 08, 2025Mike MatsonNeedham$45.00$39.2714.59%80.00%
Oct 23, 2024Daniel StauderJMP Securities$33.00$26.5324.39%32.00%
Aug 09, 2024Suraj KaliaOppenheimer$30.00$25.3318.44%20.00%
Jul 10, 2024Frank TakkinenLake Street$30.00$25.9415.65%20.00%
Jul 02, 2024Frank TakkinenLoop Capital Markets$30.00$26.0215.30%20.00%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 21, 2026CitigroupMarket OutperformMarket Outperformhold
Jul 20, 2026NeedhamBuyBuyhold
Apr 20, 2026NeedhamBuyBuyhold
Dec 17, 2025Canaccord GenuityBuyBuyhold
Nov 07, 2025OppenheimerOutperformOutperformhold
Oct 10, 2025CitigroupOutperformOutperformhold
Aug 08, 2025OppenheimerOutperformOutperformhold
Aug 08, 2025NeedhamBuyBuyhold
Oct 23, 2024Stifel NicolausMarket OutperformMarket Outperformhold
Oct 23, 2024JMP SecuritiesMarket OutperformOutperforminitialise

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-0.38$-0.48$-0.75$-0.32$0.22-
Avg Forecast$0.07$-0.66$-0.74$0.01$0.14$0.40
High Forecast$0.07$-0.64$-0.73$0.01$0.14$0.49
Low Forecast$0.07$-0.66$-0.75$0.01$0.14$0.27
Surprise %-642.86%-27.27%1.35%-3300.00%57.14%-

Revenue Forecast

$250M $300M $350M $400M $450M $500M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$298.84M$313.79M$354.00M$388.54M$441.33M-
Avg Forecast$297.24M$314.34M$349.64M$392.03M$430.23M$477.49M
High Forecast$299.81M$317.05M$349.69M$392.13M$433.66M$477.50M
Low Forecast$294.06M$310.06M$349.59M$391.93M$426.80M$477.48M
Surprise %0.54%-0.18%1.25%-0.89%2.58%-

Net Income Forecast

$-35M $-24M $-13M $-2M $9M $20M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26
Reported$-14.83M$-19.19M$-30.69M$-13.36M$9.77M-
Avg Forecast$2.72M$-26.73M$-30.57M$338.27K$5.62M$19.52M
High Forecast$2.75M$-26.25M$-29.59M$344.23K$5.71M$19.96M
Low Forecast$2.68M$-27.03M$-30.65M$332.31K$5.52M$11.00M
Surprise %-646.13%-28.19%0.40%-4049.26%73.96%-

AORT Forecast FAQ

Is Artivion stock a buy?

Artivion stock has a consensus rating of Buy, based on 12 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Artivion is a favorable investment for most analysts.

What is Artivion's price target?

Artivion's price target, set by 12 Wall Street analysts, averages $40.5 over the next 12 months. The price target range spans from $36 at the low end to $45 at the high end, suggesting a potential 62.00% change from the previous closing price of $25.

How does Artivion stock forecast compare to its benchmarks?

Artivion's stock forecast shows a 62.00% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (30.52%).

What is the breakdown of analyst ratings for Artivion over the past three months?

  • July 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • June 2026: 14.29% Strong Buy, 85.71% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 25.00% Strong Buy, 75.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Artivion’s EPS forecast?

Artivion's average annual EPS forecast for its fiscal year ending in December 2026 is $0.4, marking a 81.82% increase from the reported $0.22 in 2025..

What is Artivion’s revenue forecast?

Artivion's average annual revenue forecast for its fiscal year ending in December 2026 is $477.49M, reflecting a 8.19% increase from the reported $441.33M in 2025.

What is Artivion’s net income forecast?

Artivion's net income forecast for the fiscal year ending in December 2026 stands at $19.52M, representing an 99.84% increase from the reported $9.77M in 2025.